ABBVIE INC. vs. Wave Life Sciences Ltd. Ordinary Shares
ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABBV | WVE | |
|---|---|---|
| Market Cap | $438.19 billion | $994.11 million |
| Revenue (TTM) | — | $65.37 million |
| Net Income (TTM) | — | $-202,473,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | WVE | |
|---|---|---|
| Price / Book | — | 2.19 |
| Price / Sales | — | 15.21 |
ABBV and WVE split the valuation factors evenly.
Profitability
| ABBV | WVE | |
|---|---|---|
| Net Margin | — | -309.73% |
| Return on Equity | — | -44.64% |
ABBV and WVE split the profitability factors evenly.
Dividend
| ABBV | WVE | |
|---|---|---|
| Dividend Yield | 2.79% | — |
ABBV and WVE split the dividend factors evenly.
Risk & Sentiment
| ABBV | WVE | |
|---|---|---|
| Short Interest | 0.85% | 1.22% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, WVE overview, WVE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.